These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 24072004

  • 1. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.
    Flint AC, Faigeles BS, Cullen SP, Kamel H, Rao VA, Gupta R, Smith WS, Bath PM, Donnan GA, VISTA Collaboration.
    Stroke; 2013 Dec; 44(12):3365-9. PubMed ID: 24072004
    [Abstract] [Full Text] [Related]

  • 2. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA, SITS International and VISTA-plus investigators.
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [Abstract] [Full Text] [Related]

  • 3. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
    Kamel H, Patel N, Rao VA, Cullen SP, Faigeles BS, Smith WS, Flint AC.
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
    [Abstract] [Full Text] [Related]

  • 4. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
    Saposnik G, Reeves MJ, Johnston SC, Bath PM, Ovbiagele B, VISTA Collaboration.
    Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
    [Abstract] [Full Text] [Related]

  • 5. THRIVE score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial.
    Flint AC, Xiang B, Gupta R, Nogueira RG, Lutsep HL, Jovin TG, Albers GW, Liebeskind DS, Sanossian N, Smith WS, TREVO-2 Trialists.
    Stroke; 2013 Dec; 44(12):3370-5. PubMed ID: 24072003
    [Abstract] [Full Text] [Related]

  • 6. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
    Saposnik G, Demchuk A, Tu JV, Johnston SC, Stroke Outcomes Research Canada (SORCan) Working Group.
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
    [Abstract] [Full Text] [Related]

  • 7. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G, Fang J, Kapral MK, Tu JV, Mamdani M, Austin P, Johnston SC, Investigators of the Registry of the Canadian Stroke Network (RCSN), Stroke Outcomes Research Canada (SORCan) Working Group.
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [Abstract] [Full Text] [Related]

  • 8. Improved ischemic stroke outcome prediction using model estimation of outcome probability: the THRIVE-c calculation.
    Flint AC, Rao VA, Chan SL, Cullen SP, Faigeles BS, Smith WS, Bath PM, Wahlgren N, Ahmed N, Donnan GA, Johnston SC, SITS International and VISTA-plus investigators.
    Int J Stroke; 2015 Aug; 10(6):815-21. PubMed ID: 26045081
    [Abstract] [Full Text] [Related]

  • 9. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 10. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH, Cox M, Smith EE, Xian Y, Bhatt DL, Fonarow GC, Peterson ED, Get With The Guidelines-Stroke Program.
    Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
    [Abstract] [Full Text] [Related]

  • 11. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M, Wang-Qin RQ, Wang YL, Liu LB, Pan YS, Liao XL, Wang YJ, Xu AD.
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [Abstract] [Full Text] [Related]

  • 12. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage.
    Gumbinger C, Gruschka P, Böttinger M, Heerlein K, Barrows R, Hacke W, Ringleb P.
    Stroke; 2012 Jan; 43(1):240-2. PubMed ID: 21998049
    [Abstract] [Full Text] [Related]

  • 13. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A, Pasi M, Fiorelli M, Shams S, von Kummer R, Pantoni L, Rost N.
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [Abstract] [Full Text] [Related]

  • 14. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH, Kim BJ, Han MK, Park TH, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim JT, Choi K, Kim DE, Ryu WS, Kim WJ, Shin DI, Yeo M, Lee J, Lee JS, Gorelick PB, Bae HJ.
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [Abstract] [Full Text] [Related]

  • 15. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
    Merkler AE, Salehi Omran S, Gialdini G, Lerario MP, Yaghi S, Elkind MSV, Navi BB.
    Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
    [Abstract] [Full Text] [Related]

  • 16. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
    Lin TC, Chao TH, Shieh Y, Lee TH, Chang YJ, Lee JD, Peng TI, Chang KC, Liou CW, Chang TY, Hung KL, Chang CH.
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
    [Abstract] [Full Text] [Related]

  • 17. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, Buecker-Nott HJ, Rother J, Neundoerfer B, Kolominsky-Rabas PL, German Stroke Registers Study Group, Competence Net Stroke.
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [Abstract] [Full Text] [Related]

  • 18. Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.
    Mazya MV, Ahmed N, Ford GA, Hobohm C, Mikulik R, Nunes AP, Wahlgren N, Scientific Committee of SITS International.
    Stroke; 2014 Jun; 45(6):1657-63. PubMed ID: 24788971
    [Abstract] [Full Text] [Related]

  • 19. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Jun; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 20. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M, Matthis C, Eggers J.
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.